https://www.medicalnewstoday.com/articles/high-cholesterol-new-crispr-treatment-trial-could-offer-permanent-cure
Biotechnology company Verve Therapeutics launched the first human clinical trial for a gene-editing medication aimed at lowering cholesterol.
Create an account or login to join the discussion